Skip to content

Distractor interference after unilateral damage to the frontal, parietal or occipital system

Distractor interference after unilateral damage to the frontal, parietal or occipital system - Distractor interference after damage to cortex

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37311
Enrollment
108
Registered
2008-05-20
Start date
2008-11-01
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain damage cortical lesions

Interventions

None listed

Sponsors

Universiteit Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - aged older than 18 years and younger than 80 years - having suffered brain damage frontal, parietal or occipital systems - able to understand and carry out the test instructions

Exclusion criteria

Exclusion criteria: - psychiatric conditions that might interfere with the test performance

Design outcomes

Primary

MeasureTime frame
The main endpoint of the present study is the latency (reaction time) of the eye movement. This is measured as the time between the presentation of the target and the start of the eye movement.

Secondary

MeasureTime frame
The secondary study parameters are the saccade metrics like saccade trajectories and endpoint. Furthermore, it will be investigated whether the prismatic effect is more perceptual or more motor in nature, or a combination of both. The data for this will come from the neuropsychological neglect screening, in which changes in performance on screening tests with a strong perceptual component (e.g. Landmark task) will be compared to changes in performance on screening tests with a strong motor component (e.g. Star Cancelation). Additionally, differences in eye movements (reaction times, endpoints) between pre- and post prism adaptation will be investigated.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)